TableĀ 3

Stakeholder engagement in EQUIPT

Method of engagementEngagement purposeDefinition of stakeholderExamples
InterviewsTo learn about the needs of local policymakers for including economic evidence in their decision-making and the factors that are crucial for return on investment (ROI) adoption in sample countriesOne or more of the following: health policymakers; purchasers of services; generators of evidence leading to policy/procurement/delivery of services; advocates of health promotion; experts including clinicians and those specialising in tobacco control; financial authoritiesTwo types of stakeholder groups will be targeted: (1) National and European stakeholders consisting of policymakers, academics, health authorities, insurance companies, advocacy groups, ministry of finance, national committees, clinicians and health technology assessment (HTA) professionals and (2) Experts on smoking cessation and HTA
Consensus workshops (to be held separately in each sample country)To discuss and agree on findings and devise a set of recommendations for the next phase of the project (adaption of ROI tool in sample countries)Interviewed stakeholdersInterviewed stakeholders
Piloting of a country-specific ROI toolTo market test the relevance and applicability of the country-specific ROI toolsInterviewed stakeholdersInterviewed stakeholders
Workshop on UK policy experienceTo understand the experience of users of ROI tools on its applicability, relevance and the extent to which it has helped in developing policy proposals at local and regional levels in England. This will inform and facilitate the research process and encourage application of the findings of this research in policymaking5 regional/local and 5 national UK stakeholders with previous experience in using the ROI toolsDirectors of Public Health, service commissioners (procurers), local authority representatives (policy and strategy), tobacco control managers, advocacy group representatives
International workshopTo devise a set of policy proposals relevant to the out-of-sample countries for the implementation of evidence-based public health policies and support the validation of the ROI online toolStakeholders from those countries with limited capacity and budget for the implementation of evidence-based public health policy (mostly Central and Eastern European Countries)Central and Eastern European national representatives of: policymakers (from ministries of health, social welfare, finance and science and education); health professionals (from national public health institutes, national medical associations); researchers (from the area of public health service researchers); insurers/payers; patient organisations (condition/disease specific), HTA agencies
SurveyTo assess the project website using the I-change modelRelevant stakeholders are those agencies that may wish to use HTA assessments when making decisions about which tobacco control strategies/programmes they wish to recommend for implementation in their countryOfficers from the ministry of health responsible for Tobacco Control, relevant health organisations (eg, national Tobacco Control agencies, Heart Societies, Cancer Societies, Asthma Societies, Regional Health Authorities, Health Insurance Companies, HTA groups)
Project websiteTo make project information and results available to stakeholdersThose who are expected to use the website to access project information and resultsProject partners; potential users of the ROI tools, media; lay public
Project meetings on translation into national/local policyTo reach out to policy, practice and research communities and to raise awareness and interest for the new ROI toolRelevant stakeholders are those agencies that may wish to use HTA assessments when making decisions about which tobacco control strategies/programmes they wish to recommend for implementation in their countryStakeholders thus include officers from the ministry of health responsible for Tobacco Control, relevant health organisations (eg, national Tobacco Control agencies, Heart Societies, Cancer Societies, Asthma Societies, Regional Health Authorities, Health Insurance Companies, HTA groups)